Evidence map›Paper›PMID 34267272›Full record

ArticleScientific reports2021

Downhill hiking improves low-grade inflammation, triglycerides, body weight and glucose tolerance.

Heinz Drexel, Arthur Mader, Christoph H Saely, Gerda Tautermann, Jörn F Dopheide, Alexander Vonbank

Open access · goldAbstract readControlled Clinical Trial
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Heinz Drexel *Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria.
Arthur Mader *Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria. arthur.mader@lkhf.at.
Christoph H SaelyVorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria.
Gerda TautermannVorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria.
Jörn F DopheideDivision of Angiology, Department of Internal Medicine, Cantonal Hospital Graubuenden, Chur, Switzerland.
Alexander VonbankVorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria.
Landeskrankenhaus Feldkirch · ATVorarlberg Institute for Vascular Investigation and Treatment · ATDrexel University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exercise is a well-established tool for cardiovascular risk reduction. Particularly eccentric exercise, which essentially means walking downwards could favour more people becoming physically active. With the present controlled study, we tested the hypothesis that eccentric exercise can improve insulin sensitivity, triglyceride handling, body mass index, glucose tolerance and inflammation. We allocated 127 healthy sedentary individuals to one of two groups: (i) an active group of 102 individuals walking downwards a predefined route three to five times per week over two months, covering a difference in altitude of 540 m; for the upward route a cable car was used, for which adherence was recorded electronically and (ii) a matched control group of 25 individuals who stayed sedentary. Fasting and postprandial metabolic profiles were obtained at baseline and after two months. Compared to baseline, eccentric exercise significantly improved HOMA insulin resistance (1.94 ± 1.65 vs. 1.71 ± 1.36 (µU

Indexed as

Body Mass IndexExerciseAdultBlood GlucoseFemaleHumansInflammationInsulin ResistanceLipidsMaleMiddle AgedPostprandial PeriodProof of Concept StudySedentary BehaviorTriglyceridesWalkingBlood GlucoseLipidsTriglycerides

Identifiers

PMID34267272
PMCPMC8282605
OpenAlexW3182066187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.